Against cervical cancer, vaccine is a new beginning, Pg12

Key Highlights:

• India launched a nationwide HPV vaccination program for adolescent girls on February 28, aiming to eliminate cervical cancer.
• Cervical cancer is the fourth most common cancer among women globally, with approximately 660,000 new cases and 350,000 deaths annually.
• India reports over 78,000 new cervical cancer cases and nearly 43,000 deaths each year.
• The WHO has set a goal to reduce cervical cancer rates to fewer than 4 new cases per 100,000 women per year.
• Studies have shown that even a single dose of the HPV vaccine provides long-term protection.

Detailed Insights:

• HPV infection is the primary cause of most cervical cancers, making it a preventable disease through vaccination and screening.
• Risk factors include early marriage, early sexual activity, multiple pregnancies, tobacco use, and poor genital hygiene, all increasing infection chances.
• The WHO's "90-70-90" strategy aims for 90% HPV vaccination coverage by age 15, 70% screening rates for women 30+, and 90% treatment access for those with the disease.
• The HPV vaccine has a strong global safety record, with mild side effects like pain or redness at the injection site.
• Global data confirms the HPV vaccine's safety and effectiveness, leading to its implementation in over 140 countries.
• Progress in cervical cancer control requires sustained efforts and widespread HPV vaccination coverage to prevent resurgence.
• India's vaccination program, combined with screening and treatment, can significantly reduce cervical cancer within a generation.

Key Concepts Involved:

• Human Papillomavirus (HPV): A common virus that can cause infections in the genital area and lead to cervical cancer.
• Cervical Cancer: A type of cancer that occurs in the cells of the cervix, often caused by HPV.
• Vaccination: The process of administering a vaccine to provide immunity against a disease.